Viking Therapeutics Inc (VKTX)
76.40
-3.17
(-3.98%)
USD |
NASDAQ |
May 01, 16:00
76.69
+0.29
(+0.38%)
After-Hours: 20:00
Viking Therapeutics Cash and Short Term Investments (Quarterly): 962.98M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 962.98M |
| December 31, 2023 | 362.08M |
| September 30, 2023 | 376.24M |
| June 30, 2023 | 392.92M |
| March 31, 2023 | 135.66M |
| December 31, 2022 | 155.48M |
| September 30, 2022 | 155.02M |
| June 30, 2022 | 168.92M |
| March 31, 2022 | 184.90M |
| December 31, 2021 | 202.10M |
| September 30, 2021 | 216.14M |
| June 30, 2021 | 228.26M |
| March 31, 2021 | 241.68M |
| December 31, 2020 | 248.39M |
| September 30, 2020 | 255.30M |
| June 30, 2020 | 263.00M |
| March 31, 2020 | 269.16M |
| December 31, 2019 | 275.64M |
| September 30, 2019 | 288.07M |
| June 30, 2019 | 292.64M |
| Date | Value |
|---|---|
| March 31, 2019 | 298.72M |
| December 31, 2018 | 301.52M |
| September 30, 2018 | 304.16M |
| June 30, 2018 | 142.17M |
| March 31, 2018 | 77.47M |
| December 31, 2017 | 20.58M |
| September 30, 2017 | 9.839M |
| June 30, 2017 | 12.08M |
| March 31, 2017 | 12.31M |
| December 31, 2016 | 13.15M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 17.20M |
| March 31, 2016 | 11.25M |
| December 31, 2015 | 14.10M |
| September 30, 2015 | 17.49M |
| June 30, 2015 | 21.66M |
| March 31, 2015 | 0.327M |
| December 31, 2014 | 0.7559M |
| June 30, 2014 | 0.8915M |
| March 31, 2014 | 0.0788M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
135.66M
Minimum
Mar 2023
962.98M
Maximum
Mar 2024
283.73M
Average
251.84M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 2.928B |
| Pfizer Inc | 12.69B |
| Madrigal Pharmaceuticals Inc | 634.13M |
| Akero Therapeutics Inc | 550.01M |
| Terns Pharmaceuticals Inc | 263.44M |